MDVLQ (MedAvail Holdings) Other Long Term Assets: $0.77 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDVLQ MedAvail Holdings Inc MDVLQ
12 GF Score
Price $0.00
View Full Analysis

What is MedAvail Holdings Other Long Term Assets?

MedAvail Holdings MDVLQ 12 Other Long Term Assets is $0.77 Mil as of Jun. 2023. GuruFocus rates MDVLQ with a GF Score™ of 12/100.

MedAvail Holdings's other long-term assets for the quarter that ended in Jun. 2023 was $0.77 Mil.

MedAvail Holdings's quarterly other long-term assets increased from Dec. 2022 ($0.20 Mil) to Mar. 2023 ($1.20 Mil) but then stayed the same from Mar. 2023 ($1.20 Mil) to Jun. 2023 ($0.77 Mil).

MedAvail Holdings's annual other long-term assets increased from Dec. 2020 ($0.20 Mil) to Dec. 2021 ($0.23 Mil) but then declined from Dec. 2021 ($0.23 Mil) to Dec. 2022 ($0.20 Mil).

MedAvail Holdings Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Other Long Term Assets Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Long Term Assets
0.09 0.20 0.23 0.20

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.23 0.20 1.20 0.77
MDVLQ
12GF Score
MedAvail Holdings Inc MDVLQ
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.77 Mil mean?
MedAvail Holdings (MDVLQ) has a Other Long Term Assets of $0.77 Mil as of Jun. 2023. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on MedAvail Holdings and its competitors.
Is MedAvail Holdings' Other Long Term Assets too high?
MedAvail Holdings' current Other Long Term Assets is $0.77 Mil. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Other Long Term Assets compare to HEWA and BIMI?
MedAvail Holdings' Other Long Term Assets of $0.77 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on MedAvail Holdings and its competitors. MedAvail Holdings's current Other Long Term Assets is $0.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (MDVLQ) has a current Other Long Term Assets of $0.77 Mil. The current Other Long Term Assets is $0.77 Mil. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For MedAvail Holdings (MDVLQ), the current Other Long Term Assets is $0.77 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for MDVLQ

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price